Society for Endocrinology - a world-leading authority on hormones

Teva levothyroxine 100 microgram tablets - information from the MHRA UPDATE March 2012

17 Feb 2012


The Medicines and Healthcare products Regulatory Agency (MHRA) has suspended the licence of levothyroxine 100 microgram tablets, manufactured by Teva, for patients with hypothyroidism. Further details can be found on the MHRA website at the link below. The Society for Endocrinology is monitoring the situation and will keep you updated with any further developments.

MHRA UPDATE (March 2012)

MHRA press release (February 2012)

MHRA Q&A document on Teva levothyroxine (February 2012)